Historical record - last NADAC effective date: 12/21/2022
Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.4937 per EA under NDC 31722064001. Its NADAC has been published 207 times since Jan 23, 2019.
FDA first approved this application on Oct 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722064001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA209795FDA Approved
10/22/2018
TE Code
AB
On Market Since
10/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 207 times since Jan 23, 2019, and over the history we have for it it has declined 73.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4937 per EA |
|---|---|
| All-time high | $1.8320 (Feb 13, 2019) |
| All-time low | $0.4735 (Dec 22, 2021) |
| Median price | $0.7954 |
| Average price | $0.8939 |
| Largest weekly change | +52.5% (Nov 23, 2022) |
| Weeks tracked | 207 |
| Tracking since | Jan 23, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-32.9%
All
-73.0%
Last surveyed Jan 4, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.4937 per EA (NDC 31722064001), effective Jan 4, 2023.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 73.0%. It has been tracked across 207 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since Jan 23, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.4735 (Dec 22, 2021) to a high of $1.8320 (Feb 13, 2019), with a median of $0.7954 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBAZAM 20 MG TABLET, is $0.3902 per EA — about 21% below CLOBAZAM 20 MG TABLET.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 31722064001) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.